[go: up one dir, main page]

MX2013013339A - Uso de secnidazol en el tratamiento de infecciones dentales. - Google Patents

Uso de secnidazol en el tratamiento de infecciones dentales.

Info

Publication number
MX2013013339A
MX2013013339A MX2013013339A MX2013013339A MX2013013339A MX 2013013339 A MX2013013339 A MX 2013013339A MX 2013013339 A MX2013013339 A MX 2013013339A MX 2013013339 A MX2013013339 A MX 2013013339A MX 2013013339 A MX2013013339 A MX 2013013339A
Authority
MX
Mexico
Prior art keywords
treatment
secnidazol
dental infections
dental
infections
Prior art date
Application number
MX2013013339A
Other languages
English (en)
Inventor
Pierre-Marie Defrance
Original Assignee
Madeca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44352217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013013339(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Madeca filed Critical Madeca
Publication of MX2013013339A publication Critical patent/MX2013013339A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La asociación de secnidazol a un antibiótico de la familia de los macrólidos, preferentemente azitromicina, para el tratamiento por vía oral de infecciones dentales, lo que permite reducir considerablemente la duración del tratamiento y las dosis administradas con relación al tratamiento convencional.
MX2013013339A 2011-05-16 2012-05-14 Uso de secnidazol en el tratamiento de infecciones dentales. MX2013013339A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1101478A FR2975299B1 (fr) 2011-05-16 2011-05-16 Utilisation du secnidazole dans le traitement des infections dentaires
PCT/FR2012/000192 WO2012156599A1 (fr) 2011-05-16 2012-05-14 Utilisation du secnidazole dans le traitement des infections dentaires

Publications (1)

Publication Number Publication Date
MX2013013339A true MX2013013339A (es) 2013-12-02

Family

ID=44352217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013339A MX2013013339A (es) 2011-05-16 2012-05-14 Uso de secnidazol en el tratamiento de infecciones dentales.

Country Status (15)

Country Link
US (1) US9700574B2 (es)
EP (1) EP2709617B1 (es)
KR (1) KR20140056179A (es)
CN (1) CN103596565B (es)
BR (1) BR112013028872B1 (es)
CL (1) CL2013003268A1 (es)
CO (1) CO6801770A2 (es)
ES (1) ES2562163T3 (es)
FR (1) FR2975299B1 (es)
MX (1) MX2013013339A (es)
PH (1) PH12013502335A1 (es)
PL (1) PL2709617T3 (es)
RU (1) RU2013150335A (es)
WO (1) WO2012156599A1 (es)
ZA (1) ZA201308025B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
CN1559428A (zh) * 2004-03-11 2005-01-05 金春华 一种含有塞克硝唑的根除幽门螺旋杆菌的复方药物

Also Published As

Publication number Publication date
US9700574B2 (en) 2017-07-11
EP2709617A1 (fr) 2014-03-26
BR112013028872B1 (pt) 2020-01-28
EP2709617B1 (fr) 2015-11-25
FR2975299B1 (fr) 2013-09-27
WO2012156599A1 (fr) 2012-11-22
ES2562163T3 (es) 2016-03-02
KR20140056179A (ko) 2014-05-09
RU2013150335A (ru) 2015-06-27
CN103596565B (zh) 2017-06-20
CL2013003268A1 (es) 2014-07-04
PH12013502335A1 (en) 2019-03-22
BR112013028872A2 (pt) 2017-01-31
FR2975299A1 (fr) 2012-11-23
CN103596565A (zh) 2014-02-19
US20140080778A1 (en) 2014-03-20
CO6801770A2 (es) 2013-11-29
ZA201308025B (en) 2015-04-29
PL2709617T3 (pl) 2016-05-31

Similar Documents

Publication Publication Date Title
GT201500088A (es) Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih
CL2017000156A1 (es) Procedimientos para el tratamiento de paramixovirus.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CL2016000698A1 (es) Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
ES2609857T3 (es) 4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H-imidazo[4,5-C]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor de bromodominios
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
DOP2011000260A (es) Pirimidinas fusionadas
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
ECSP13013011A (es) Triazolopiridinas
DOP2014000133A (es) Triazolopiridinas sustituidas
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
CO6650348A2 (es) Triazolopiridinas sustituidas
UY33984A (es) Uso de 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas
MX2017000627A (es) Metodos para tratar pacientes con hipercolesterolemia familiar heterocigota (hfhe).
DOP2014000081A (es) Compuestos y procedimientos para mejorar las respuestas inmunitarias innatas
MX2015014097A (es) Tratamiento de cancer empleando terapias combinadas de coenzima q10.
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
CR20130569A (es) Análogos del ácido epoxieicosatrienoicos y métodos de toma y uso del mismo
AR097619A1 (es) Uso de inhibidores de acetil-coa carboxilasa para tratar acné vulgaris
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CU20160072A7 (es) Tienopirimidinas como inhibidores mknk1 y mknk2

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: VEGEFARM

FA Abandonment or withdrawal